This was one of the key messages among many topics coming out of the Healthcare
Innovation Expolast week in Londonas the new CCG structure gears up
for the 1st of April.
From an adherence perspective, it was particularly refreshing to hear both clinicians, pharma
companies and members of the Clinical Commissioning Groups talk about ‘understanding
the patient journey’ and helping patient’s lead more healthy lives.
This was an innovation event so understandably the word on the street was all about the
latest telemedicine platforms out there and the positive impact technology can play in
improving patient health. But, actually implementing this technology and making it a
cost-efficient process to the benefit of primarily patients as wellas clinicians was a big
talking point over the two days.
Doctor Shahid Ali from the Phoenix Medical Practice in Bradford, Yorkshire was particularly
interesting around the patient setting objectives to be accountable for their own health.
Telemedicine along with data and information, being one of the ways that clinicians can
support patients in achieving their goals and ultimately take control of their health.
From the pharmaceutical industry, Jackie Parkin from GSK gave a very insightful seminar
on ‘adhering to adherence’. Jackie outlined that the adherence challenge will not go away
and it is up to all the key stakeholders (payers, clinicians, patients, providers and
pharmaceutical companies) in the process to keep working at identifying where the key
information gaps are.
There is no doubt that technology will improve the overall objective of improving patient
outcomes but understanding what the individual goes through in becoming a patient and
the treatment journey they have to undertake – is still the big challenge. The healthcare
industry is growing increasingly aware of this issue, but putting all the right pieces of this
new CCG puzzle together with the end goal of improving patient health, still has some way